Evidence map›Paper›PMID 29653536›Full record

ArticleBMC public health2018

Acceptability of HIV self-sampling kits (TINY vial) among people of black African ethnicity in the UK: a qualitative study.

C Dodds, E Mugweni, G Phillips, C Park, I Young, I Fakoya, S Wayal, L McDaid, M Sachikonye, J Chwaula and 2 more

Erratum issued Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05690607 (Small Volume Blood Testing Validity and Acceptability for HIV-1 and Hepatitis B), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05690607 unknown statusnot on this mapstarted 2023, after this paper: background citation

Small Volume Blood Testing Validity and Acceptability for HIV-1 and Hepatitis B

TypeobservationalSponsorCentral and North West London NHS Foundation TrustRan2023 to 2024Enrolled300ConditionsHIV Infections, Hepatitis BArmsDoctors Laboratory TINIES small volume blood testing kit
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

C DoddsLondon School of Hygiene and Tropical Medicine, London, UK. catherine.dodds@glasgow.ac.uk.ORCID 0000-0003-1738-5819
E MugweniUniversity College London, London, UK.
G PhillipsUniversity of Glasgow, Glasgow, UK.
C ParkUniversity of Glasgow, Glasgow, UK.
I YoungUniversity of Glasgow, Glasgow, UK.
I FakoyaUniversity College London, London, UK.
S WayalUniversity College London, London, UK.
L McDaidUniversity of Glasgow, Glasgow, UK.
M SachikonyeUK Community Advisory Board for HIV and iBase, London, UK.
J ChwaulaBHA for Equality, Manchester, UK.
P FlowersGlasgow Caledonian University, Glasgow, UK.
F BurnsUniversity College London, London, UK.
University of Glasgow · GBUniversity College London · GBGlasgow Caledonian University · GBLondon School of Hygiene & Tropical Medicine · GBRace Equality Foundation · GBRoyal Free London NHS Foundation Trust · GB

Funding

Chief Scientist Office SPHSU11Department of Health 12/138/02Health Technology Assessment Programme 12/138/02Medical Research Council MC_UU_12017/11
6 · The paper itself

Abstract

backgroundIncreasing routine HIV testing among key populations is a public health imperative, so improving access to acceptable testing options for those in need is a priority. Despite increasing targeted distribution and uptake of HIV self-sampling kits (SSKs) among men who have sex with men in the UK, little is known about why targeted SSK interventions for black African users are not as wide-spread or well-used. This paper addresses this key gap, offering insight into why some groups may be less likely than others to adopt certain types of SSK interventions in particular contexts. These data were collected during the development phase of a larger study to explore the feasibility and acceptability of targeted distribution of SSKs to black African people.

methodsWe undertook 6 focus groups with members of the public who self-identified as black African (n = 48), 6 groups with specialists providing HIV and social services to black African people (n = 53), and interviews with HIV specialist consultants and policy-makers (n = 9). Framework analysis was undertaken, using inductive and deductive analysis to develop and check themes.

resultsWe found three valuable components of targeted SSK interventions for this population: the use of settings and technologies that increase choice and autonomy; targeted offers of HIV testing that preserve privacy and do not exacerbate HIV stigma; and ensuring that the specific kit being used (in this case, the TINY vial) is perceived as simple and reliable.

conclusionsThis unique and rigorous research offers insights into participants' views on SSK interventions, offering key considerations when targeting this population.. Given the plethora of HIV testing options, our work demonstrates that those commissioning and delivering SSK interventions will need to clarify (for users and providers) how each kit type and intervention design adds value. Most significantly, these findings demonstrate that without a strong locus of control over their own circumstances and personal information, black African people are less likely to feel that they can pursue an HIV test that is safe and secure. Thus, where profound social inequalities persist, so will inequalities in HIV testing uptake - by any means.

Indexed as

Self CareAdolescentAdultBlack PeopleFeasibility StudiesFemaleFocus GroupsHIV InfectionsHumansMaleMass ScreeningMiddle AgedPatient Acceptance of Health CareQualitative ResearchSpecimen HandlingUnited KingdomAfricanEthnicityFeasibilityHIVQualitativeSelf-samplingTestingUnited Kingdom

Identifiers

PMID29653536
PMCPMC5899406
OpenAlexW2794683272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.